The role of the T cell in the immunopathogenesis of asthma

Chemical Immunology

Volumn 78, Issue , 2000, Pages 39-49

  Corrigan, C J ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; RANTES; VASCULAR CELL ADHESION MOLECULE 1; ALLERGEN; ANTIASTHMATIC AGENT; CHEMOKINE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN DERIVATIVE;

ANTIGEN ANTIBODY COMPLEX; ASTHMA; B LYMPHOCYTE; CYTOKINE RELEASE; DISEASE SEVERITY; EFFECTOR CELL; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; LUNG LAVAGE; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; T LYMPHOCYTE; TH1 CELL; ADULT; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CHILD; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG RESISTANCE; GENETICS; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ALLERGENS; ANTI-ASTHMATIC AGENTS; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CHILD; CYCLOSPORINE; DOUBLE-BLIND METHOD; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKINS; LYMPHOCYTE ACTIVATION; RANDOMIZED CONTROLLED TRIALS; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 0033795068     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058815     Document Type: Review

References (30)

1. T-lymphocyte activation in acute severe asthma
2. CD4 T-lymphocyte activation in acute severe asthma: Relationship to disease severity and atopic status
3. Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: Effect of glucocorticoid therapy
4. Peripheral blood CD4, but not CD8 T lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: Effect of glucocorticoid therapy
5. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5: Effect of glucocorticoid therapy
6. Serum interleukin-5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma
7. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
8. Predominant Th2-type bronchoalveolar lavage T-lymphocyte population in atopic asthma
9. Phenotype of cells expressing mRNA for Th2-type (interleukin-4 and interleukin-5) and Th1-type (interleukin-2 and interferon-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects
10. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils and mast cells in bronchial biopsies obtained from atopic and non-atopic (intrinsic) asthmatics
11. Late phase response to allergen is associated with increased concentrations of TNF- and IL-5 in induced sputum
12. Glucocorticoid resistance in chronic asthma: Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro
13. Glucocorticoid resistance in chronic asthma: Peripheral blood T-lymphocyte activation and a comparison of the T-lymphocyte inhibitory effects of glucocorticoids and cyclosporin A
14. Glucocorticoid-resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents
15. The effect of dexamethasone, cyclosporine and rapamycin on T-lymphocyte proliferation in vitro: Comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma
16. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma
17. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma
18. Can clinical response to cyclosporin in chronic severe asthma be predicted by an in vitro T-lymphocyte proliferation assay?
19. Effects of rapamycin, cyclosporin A and dexamethasone on interleukin-5-induced eosinophil degranulation and prolonged survival
20. Clinical response to cyclosporin in chronic severe asthma is associated with a reduction in serum soluble interleukin-2 receptor concentrations
21. Inhibition of re-expression of surface CD4, but not CD8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine A: Correlation with inhibition of proliferation
22. Activated peripheral blood CD4 and CD8 T lymphocytes in childhood asthma: Correlation with eosinophilia and disease severity
23. Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression
24. IL-4 and IL-5 messenger RNA and protein in bronchial biopsies from patients with atopic and non-atopic asthma: Evidence against 'intrinsic' asthma being a distinct immunopathologic entity
25. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and non-atopic asthmatics: Relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte/macrophage colony-stimulating factor and IL-3
26. The relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma
27. IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: Relationship to expression of allergic disease
28. IL-13 production by allergen-stimulated T cells is increased in allergic diseases and associated with IL-5, but not IFN-γ expression
29. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls
30. Allergen-induced proliferation and IL-5 production by bronchoalveolar lavage and blood T cells following segmental allergen challenge